CASBF
Price:
$3.97
Market Cap:
$12.91B
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It also develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. Further, the company develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial;...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2020-01-02
Stock Exchange
OTC
Ticker
CASBF
According to CanSino Biologics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.26B. This represents a change of 11.74% compared to the average of 11.87B of the last 4 quarters.
The mean historical Enterprise Value of CanSino Biologics Inc. over the last ten years is 46.53B. The current 13.26B Enterprise Value has changed 2.75% with respect to the historical average. Over the past ten years (40 quarters), CASBF's Enterprise Value was at its highest in in the June 2021 quarter at 198.37B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.
Average
46.53B
Median
51.84B
Minimum
0
Maximum
81.97B
Discovering the peaks and valleys of CanSino Biologics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 32.58%
Maximum Annual Enterprise Value = 81.97B
Minimum Annual Increase = -100.00%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 0 | -100.00% |
| 2024 | 15.58B | -16.09% |
| 2023 | 18.56B | -47.55% |
| 2022 | 35.39B | -49.45% |
| 2021 | 70.01B | -14.59% |
| 2020 | 81.97B | 2.63% |
| 2019 | 79.86B | 32.58% |
| 2018 | 60.24B | 7.81% |
| 2017 | 55.87B | 16.86% |
The current Enterprise Value of CanSino Biologics Inc. (CASBF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.38B
5-year avg
27.91B
10-year avg
46.53B
CanSino Biologics Inc.’s Enterprise Value is less than Tsumura & Co. (349.89B), less than Hisamitsu Pharmaceutical Co., Inc. (323.97B), greater than Sihuan Pharmaceutical Holdings Group Ltd. (8.86B), greater than Curaleaf Holdings, Inc. (2.72B), greater than Dermapharm Holding SE (3.07B), greater than Almirall, S.A. (2.47B), greater than Fagron N.V. (1.93B), less than China Medical System Holdings Limited (25.25B), less than Aspen Pharmacare Holdings Limited (85.76B), less than Nippon Shinyaku Co., Ltd. (296.26B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 349.89B | $2.09B | |
| 323.97B | $2.03B | |
| 8.86B | $1.71B | |
| 2.72B | $1.79B | |
| 3.07B | $2.13B | |
| 2.47B | $3.29B | |
| 1.93B | $1.98B | |
| 25.25B | $2.25B | |
| 85.76B | $3.79B | |
| 296.26B | $2.16B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CanSino Biologics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CanSino Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CanSino Biologics Inc.'s Enterprise Value?
What is the highest Enterprise Value for CanSino Biologics Inc. (CASBF)?
What is the 3-year average Enterprise Value for CanSino Biologics Inc. (CASBF)?
What is the 5-year average Enterprise Value for CanSino Biologics Inc. (CASBF)?
How does the current Enterprise Value for CanSino Biologics Inc. (CASBF) compare to its historical average?